Analysts expect CNS Pharmaceuticals, Inc. to report revenue of 0.00 for 2021, against a range of 0.00 to 0.00.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | - | ||||||
| High Estimate | 0.00 | 0.00 | ||||||
| Low Estimate | 0.00 | 0.00 | ||||||
| Consensus Estimate | 0.00 | 0.00 |
Analysts expect CNS Pharmaceuticals, Inc. to report earnings per share of -0.28 for Q3 26, against a range of -0.30 to -0.26. The most recent reported quarter, Q2 26, came in at -0.38, a 65.2% miss against the -0.23 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -150.00 | -447.96 | -18.96 | -6.42 | -5.76 | -5.09 | -7.30 | -0.38 | - | - | - | - |
| High Estimate | -53.36 | -86.11 | -21.77 | -9.39 | -5.77 | -4.34 | -5.28 | -0.22 | -0.26 | -0.27 | -0.44 | -0.37 |
| Low Estimate | -59.94 | -97.31 | -24.97 | -10.97 | -6.75 | -5.18 | -5.86 | -0.24 | -0.30 | -0.29 | -0.46 | -0.39 |
| Consensus Estimate | -56.65 | -91.71 | -23.37 | -10.18 | -6.26 | -4.76 | -5.57 | -0.23 | -0.28 | -0.28 | -0.45 | -0.38 |
Pull Wall Street consensus for CNS Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CNSP&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CNSP", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CNSP&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();